Our industry partners are vital in order to achieve the consortium goals.
Eagle Genomics is a true pioneer in data driven discovery. Their award winning smart data platform has revolutionised data access and management in the life sciences industry. This has delivered widespread benefits to their range of clients in the pharmaceutical, biotech, healthcare and personal care sectors. The company is based in Cambridge, England. Read more about them on their website.
GlaxoSmithKline have three world-leading businesses that research, develop and manufacture innovative pharmaceutical medicines, vaccines and consumer healthcare products. They are committed to widening access to their products, so more people can benefit, no matter where they live in the world or what they can afford to pay. The company is based in Stevenage, England. Read more about them on their website.
Critical Path Institute (C-Path)
Critical Path Institute (C-Path) is a nonprofit, public-private partnership with the Food and Drug Administration (FDA). The company's aim is to accelerate the pace and reduce the costs of medical product development through the creation of new data standards, measurement standards, and methods standards that aid in the scientific evaluation of the efficacy and safety of new therapies. They are based in Arizona, United States.
Within C-Path we are partnering with PSTC. They bring together pharmaceutical companies to share and validate innovative safety testing methods under advisement of the FDA (U.S. Food and Drug Administration), its European counterpart, the EMA (European Medicines Agency), and PMDA (Japanese Pharmaceutical and Medical Devices Agency). They have many other partner organisations, including government & regulatory agencies, non-profit research organisations and pharmaceutical industry. A key industry partners within C-Path who is partnering with APPreSci is Merck - read more about them and their partners on their website. Additionally, we have drug-induce pancreatic toxicity pathology expertise from Novartis, through PSTC - read more about them on their website.
DC Biosciences pharmaceutical and biotech companies with novel technologies and proteomics services to accelerate the development of safer drugs. They have developed a quantitative proteomics-based technology portfolio. This offers solutions to preclinical activities of the drug discovery process and developed new processes for biomarker discovery and validation, drug re-profiling and repositioning. The company is based in Dundee, Scotland. Read more about them on their website.
Stratified Medicine Scotland InNOVATION CENTRE (SMS-IC)
SMS-IC’s focus is on linking Scotland’s domain expertise, data assets and delivery capability to accelerate the adoption of Precision Medicine: new products and services for a global market. The company is based at the Queen Elizabeth University Hospital (QEUH) in Glasgow, Scotland. Read more about them on their website.
Edinburgh Genomics is a world leading genomics and bioinformatics facility delivering high volume data and cutting-edge analyses to a large community of collaborators and customers across academia, government, and industry.
The company is embedded in the intense academic environment ofThe University of Edinburgh, spanning medical, veterinary and biological realms. Read more about them on their website.
The UK Biocentre provides services to biomedical and clinical researchers. The centre has a core service designed with flexibility in mind to meet the needs of a wide variety of research. This includes sample collection, logistics and processing as well as distribution and analysis. Read more about them on their website.
See a map with all our different partners on our 'Who is APPreSci?' page.